ArticleBrain communications2024

Serum myostatin as a candidate disease severity and progression biomarker of spinal muscular atrophy.

Ana Letícia Amorim de Albuquerque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.